Factors affecting postoperative blood loss in children undergoing cardiac surgery

Area of Science:

• Pediatric Cardiac Surgery
• Hematology
• Congenital Heart Defects

Background:

• Cyanotic heart disease is a significant risk factor for complications in pediatric cardiac surgery.
• Age is a critical determinant in managing perioperative blood loss and coagulopathy in neonates and infants.

Discussion:

• The study highlights a complex relationship between cyanotic disease, age, and postoperative blood loss in pediatric cardiac surgery.
• Fresh frozen plasma administration during cardiopulmonary bypass in neonates with cyanotic disease correlated with improved hemostatic parameters.

Key Insights:

• Cyanotic disease is linked to increased postoperative bleeding in infants aged 1-6 months undergoing cardiac surgery.
• Neonates (<1 month) with cyanotic disease receiving fresh frozen plasma exhibited reduced blood loss and enhanced clot firmness (FIBTEM).

Outlook:

• Further research is essential to establish evidence-based, pathophysiology-driven management strategies for pediatric cardiac surgery patients.
• Optimizing transfusion protocols and understanding age-specific coagulopathic mechanisms are crucial for improving outcomes.